Electra Therapeutics, Inc. (NASDAQ:ETRA – Get Free Report) Director Carl Gordon acquired 22,700 shares of Electra Therapeutics stock in a transaction that occurred on Tuesday, November 10th. The stock was purchased at an average price of $8.45 per share, with a total value of $191,815.00. Following the transaction, the director owned 5,255,278 shares of the […]

Electra Therapeutics, Inc. (NASDAQ:ETRA – Get Free Report) Director Orbimed Advisors Llc bought 245,113 shares of the company’s stock in a transaction dated Tuesday, November 3rd. The stock was purchased at an average cost of $7.86 per share, for a total transaction of $1,926,588.18. Following the completion of the acquisition, the director owned 5,175,604 shares […]

Bambusa Therapeutics, Inc. (NASDAQ:BBTX – Get Free Report) Director Ra Capital Management, L.P. acquired 453,820 shares of the stock in a transaction dated Friday, October 30th. The stock was acquired at an average price of $14.63 per share, for a total transaction of $6,639,386.60. Following the completion of the acquisition, the director directly owned 453,820 […]

Rapport Therapeutics, Inc. (NASDAQ:RAPP – Get Free Report) Director James Healy acquired 969,480 shares of the company’s stock in a transaction dated Wednesday, October 28th. The shares were acquired at an average cost of $21.00 per share, with a total value of $20,359,080.00. Following the completion of the purchase, the director owned 2,815,707 shares in […]